FDA Approved Thyrosafe Potassium Iodide (KI) Tablets - Protects Against Radioactive Iodine

IMPORTANT NOTE: This product cannot be shipped to Canada. For Canadian customers, please see MIRA Safety Potassium Iodide Tablets. Why Thyroid Protection is Critical in Radiation Emergencies Your thyroid gland—a small, butterfly-shaped organ weighing roughly 20–60 grams—regulates metabolism, heart rate, body weight, muscle strength, body temperature, and nervous system function. During nuclear incidents (reactor accidents, fallout), radioactive iodine (I-131) released into the environment concentrates in the thyroid, significantly increasing cancer risks. Infants, children and pregnant/breastfeeding women face the highest danger due to developing thyroid tissue. Thyrosafe Potassium Iodide is Your First-Line Defense Blocks I-131 Absorption: Saturates the thyroid with stable iodine, preventing uptake of harmful radioactive iodine. FDA-Approved: One of the few FDA-approved KI tablets, manufactured to strict pharmaceutical standards for safety and efficacy. Time-Sensitive Protection: Must be taken before or immediately after exposure for maximum effectiveness. Key Features & Benefits FDA-Approved Reliability: Meets rigorous U.S. FDA quality and safety standards for potassium iodide thyroid-blocking tablets. Precision Dosing: 65 mg tablets feature deep cross-scoring for accurate splitting. Unit Hygiene & Storage: Individually sealed 65 mg tablets for secure handling and inventory control. Child-Friendly Administration: Tablets can be crushed and mixed with water, juice, formula, or soft food. Long Shelf Life: 10-year stability when stored properly (cool, dry place). Proven Safety Profile: Side effects are rare and typically mild (e.g., gastrointestinal upset). Trusted Manufacturing: Produced in an EU-certified facility in France with 20+ years of KI expertise. How Thyrosafe Potassium Iodide Works: The Science The thyroid requires iodine to produce hormones and cannot distinguish between stable iodine (KI) and radioactive iodine (I-131). Thyrosafe delivers a high dose of stable iodine, rapidly saturating (“filling”) the gland and preventing absorption of I-131 for ~24 hours per dose. Crucial timing: KI is only effective if taken shortly before or immediately after exposure. It does not protect against other radionuclides or external radiation. Dosing Guidelines & Emergency Protocol Age Group Potassium Iodide Dose Thyrosafe Tablets (65 mg) Duration per Dose Newborns (Birth–1 mo) 16 mg ¼ tablet ~24 hours Infants (1 mo–3 yrs) 32 mg ½ tablet ~24 hours Children (3–18 yrs) 65 mg 1 tablet ~24 hours Adults (18+ yrs) 130 mg 2 tablets ~24 hours Breastfeeding Women 130 mg 2 tablets ~24 hours Children ≥150 lb: Use adult dose (130 mg). Adults >40 Years: Lower thyroid-cancer risk but higher KI side-effect risk; follow public-health direction. Single-Dose Duration: ~24 hours—do not repeat without official guidance. I-131 Half-Life: ~8 days (most risks diminish within 10–14 days). Nuclear Preparedness: Why You Need Thyrosafe 103 Nuclear Reactors in the U.S.: Potential exposure zones can extend well beyond the immediate vicinity—historically cited as up to ~200 miles downwind depending on conditions. Thyroid Cancer Prevention: Significantly reduces I-131 thyroid-cancer risk, especially in children. Recommended Supply: Maintain one 10-day supply box per household member; store with emergency supplies for immediate access. Protect Your Family’s Thyroid Health Trust FDA-Approved Thyrosafe KI. 10-Year Shelf Life — ready when needed Proven Protection — essential for radiation emergency kits Pharmaceutical-Grade Manufacturing — consistent quality Order Thyrosafe Potassium Iodide Tablets today.